Advanced Biomed Inc
NASDAQ:ADVB
Advanced Biomed Inc
Research & Development
Advanced Biomed Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Advanced Biomed Inc
NASDAQ:ADVB
|
Research & Development
-$909.8k
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CareDx Inc
NASDAQ:CDNA
|
Research & Development
-$71.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-23%
|
|
|
Veracyte Inc
NASDAQ:VCYT
|
Research & Development
-$69.2m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-18%
|
|
|
Neogenomics Inc
NASDAQ:NEO
|
Research & Development
-$35m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
-24%
|
|
Advanced Biomed Inc
Glance View
Advanced Biomed Inc is a US-based company operating in industry. The company is headquartered in Reno, Nevada and currently employs 40 full-time employees. The company went IPO on 2025-03-06. Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The firm is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. The company has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The firm offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.
See Also
What is Advanced Biomed Inc's Research & Development?
Research & Development
-909.8k
USD
Based on the financial report for Jun 30, 2025, Advanced Biomed Inc's Research & Development amounts to -909.8k USD.
What is Advanced Biomed Inc's Research & Development growth rate?
Research & Development CAGR 3Y
17%
Over the last year, the Research & Development growth was -3%. The average annual Research & Development growth rates for Advanced Biomed Inc have been 17% over the past three years .
